Auxilium Health Announces Successful $1.5M Pre-Seed Funding Round and NSF Grant

neurons brain neural network cells nerves virus biology biotech neurons neural network neural network neural network biotech biotech biotech biotech biotech

AI-assisted, human-published

Ohio-based startup surpasses $1.2M funding target, attracting regional investors and NSF support for its advanced biomaterial technology addressing non-healing wounds. Founded in 2022, the company's groundbreaking platform has attracted significant attention, setting the stage for rapid growth and impact.

Auxilium Health, a biotech startup based in Ohio, has closed an oversubscribed pre-seed funding round, raising $1.5 million, surpassing its initial target of $1.2 million. The round was led by regional investors and supported by a $275,000 grant from the National Science Foundation (NSF).

Founded in 2022, Auxilium Health focuses on advanced biomaterials for skin tissue regeneration and infection management, addressing a critical medical need affecting over 6.5 million people in the U.S. The technology, developed from polymer research at the University of Akron, has garnered national and international interest, positioning the company for significant growth and impact.

Source: PR NewsWire